MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction

Recruiting

Phase 2

Phase 3

MitoQMitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction

Sponsor:

Mclean Hospital

Code:

NCT06191965

Conditions

Schizophrenia and Related Disorders

Mitochondrial Alteration

Cognitive Impairment

Eligibility Criteria

Sex: All

Age: 18 - 35

Healthy Volunteers: Not accepted

Interventions

MitoQ

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Mclean Hospital on 2025-02-07.